SCHEMBL4069875

SCHEMBL4069875

Cc1cnccc1OCC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 1/20 0.40
AAK1 Q2M2I8 2/20 0.38
MELK Q14680 1/20 0.38
TLR8 Q9NR97 1/20 0.37
SSTR4 P31391 1/20 0.37
S1PR1 P21453 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
NR3C1 P04150 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4069873 0.80 ALDH1A1 (0.39) ALDH1A1KDM4ENPC1LMNAHPGD
SCHEMBL4079147 0.79 CA12 (0.54) ALDH1A1HPGDSSTR4S1PR1CA12
SCHEMBL11153943 0.77 ADRB1 (0.66) ALDH1A1LMNATSHRHSD17B10CYP1A2
SCHEMBL564811 0.76 XDH (0.49)
SCHEMBL4070510 0.76 PDE5A (0.40) ALDH1A1KDM4ENPC1HPGDRAB9A
SCHEMBL4072595 0.75 NOTUM (0.37) ALDH1A1LMNATLR8CA12CA1
SCHEMBL4074485 0.74 LOX (0.42) ALDH1A1LMNATLR8SSTR4CA12
SCHEMBL12877969 0.74 CYP2D6 (0.49) ALDH1A1KDM4ENPC1LMNATSHR
SCHEMBL27290458 0.74 CYP17A1 (0.43) LMNATSHRSSTR4CA12CA1
SCHEMBL23934639 0.74 AOC1 (0.41) ALDH1A1KDM4ENPC1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572918-B2 Prepared in high yield and high purity without the need for isolation of intermediates and chromatographic purification; useful as muscarinic receptor antagonists; 4-{N-[7-(3-(S)-1-carbamoyl-1,1-diphenylmethyl)-pyrrolidin-1-yl)-hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)-piperidine THERAVANCE, INC. (US) 2009-08-11 US disclosed
US-20080091034-A1 Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds THERAVANCE, INC. 2008-04-17 US disclosed
US-7285564-B2 Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds THERAVANCE, INC. (US) 2007-10-23 US disclosed
EP-1556372-B1 SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL) PIPERIDINE AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE INC (US) 2007-05-30 EP disclosed
US-20060094878-A1 Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds THERAVANCE, INC. 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094878-A1 Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds CHRM4, CHRM3, CHRM1 ALDH1A1 1356/4885KDM4E 682/4885NPC1 3900/4885
US-20080091034-A1 Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds CHRM5, CHRM1, CHRM3 ALDH1A1 807/4885KDM4E 935/4885NPC1 4293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.